Suchergebnisse - "da Silva, Ricardo Eccard"

PubPharm (9)

1

National governance and excess mortality due to COVID-19 in 213 countries : a retrospective analysis and perspectives on future pandemics

enthalten in: Globalization and health | 2023

von da Silva, R. | Novaes, M. | de Oliveira, C. | +1

2

Post-marketing authorisation safety and efficacy surveillance of advanced therapy medicinal products in Brazil, the European Union, the United States and Japan

enthalten in: Cytotherapy | 2023

von Gomes, K. | da Silva, R. | da Silva, J. | +2

3

Comparison of new Brazilian legislation for the approval of advanced therapy medicinal products with existing systems in the USA, European Union and Japan

enthalten in: Cytotherapy | 2022

von Gomes, K. | da Silva, R. | da Silva Junior, J. | +1

4

The High "Cost" of Experimental Drugs Obtained Through Health Litigation in Brazil

enthalten in: Frontiers in pharmacology | 2020

von da Silva, R. | Lima, E. | Novaes, M. | +1

5

The patient's safety and access to experimental drugs after the termination of clinical trials : regulations and trends

enthalten in: European journal of clinical pharmacology | 2018

von da Silva, R. | Amato, A. | Sousa, T. | +2

6

The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends

enthalten in: European journal of clinical pharmacology | 2018

von da Silva, R. | Amato, A. | Sousa, T. | +2

7

The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends

enthalten in: European journal of clinical pharmacology | 2018

von da Silva, R. | Amato, A. | Sousa, T. | +2

8

The patient’s safety and access to experimental drugs after the termination of clinical trials: regulations and trends

enthalten in: European journal of clinical pharmacology | 2018

von da Silva, R. | Amato, A. | Sousa, T. | +2

9

Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries

enthalten in: Journal of oncology | 2018

von da Silva, R. | Amato, A. | Andrade, D. | +3

1
[1]